Topics and Expertise: QBI

UCSF School of Pharmacy Leads $30M Award to Speed Drug Development with AI

The Department of Bioengineering and Therapeutic Sciences (BTS) chair is leading a multidisciplinary team that will receive federal funding to prevent side effects before drugs go to clinical trials.

School of Pharmacy leads in NIH funding for the 44th straight year

School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

School of Pharmacy faculty recognized among Highly Cited Researchers

The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the School’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.

UCSF School of Pharmacy leads in NIH funding for the 42nd straight year

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school for the 42nd consecutive year.

Map of protein systems reveals new targets for cancer treatment

Scientists at the UCSF Quantitative Biosciences institute developed a new approach for understanding cancer and applied it to breast cancer and cancers of the neck and head

How cells multitask: the magic of molecular switches

Research unearths new details about the protein networks that keep cells healthy

Cancer drug stops SARS-CoV-2 in the lab

“If you get a drug that targets a human protein, it would be incredibly hard for the virus to mutate away from being reliant on it,” said Nevan Krogan, the director of QBI.

Pages